Mounjaro KwikPen 2.5 mg Solution For Injection (1 Pen 4 Doses)
Key features:
Mounjaro KwikPen is a once-weekly injectable containing Tirzepatide, a dual GIP and GLP-1 receptor agonist. It is used for type 2 diabetes management and weight management in adults, alongside diet and exercise. Tirzepatide improves blood sugar control, reduces appetite, and supports fat loss. It is administered subcutaneously, with doses starting at 2.5 mg weekly and titrated up to 15 mg based on tolerance and response.
Your Dynamic Snippet will be displayed here...
This message is displayed because youy did not provide both a filter and a template to use.
Sample
Chair
1.00 EGP
Sample
Lamp
1.00 EGP
Sample
Whiteboard
1.00 EGP
Sample
Drawer
1.00 EGP
Sample
Box
1.00 EGP
Sample
Bin
1.00 EGP
Sample
Chair
1.00 EGP
Sample
Lamp
1.00 EGP
Sample
Whiteboard
1.00 EGP
Sample
Drawer
1.00 EGP
Sample
Box
1.00 EGP
Sample
Bin
1.00 EGP
Sample
Chair
1.00 EGP
Sample
Lamp
1.00 EGP
Sample
Whiteboard
1.00 EGP
Sample
Drawer
1.00 EGP